HER2/ErbB2 Activates HSF1 and Thereby Controls HSP90 Clients Including MIF in HER2-overexpressing Breast Cancer

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2013.508
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MNK1 and MNK2 Regulation in HER2-overexpressing Breast Cancer Lines

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2013English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2013English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

JAMA Oncology
Cancer ResearchOncology
2019English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

ErbB2/HER2-specific NK Cells for Adoptive Cancer Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy